Taming the Notch Transcriptional Regulator for Cancer Therapy

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Luca TamagnoneMichael Rehman

Abstract

Abstract Notch signaling is a highly conserved pathway in all metazoans, which is deeply involved in the regulation of cell fate and differentiation, proliferation and migration during development. Research in the last decades has shown that the various components of the Notch signaling cascade are either upregulated or activated in human cancers. Therefore, its downregulation stands as a promising and powerful strategy for cancer therapy. Here, we discuss the recent advances in the development of small molecule inhibitors, blocking antibodies and oligonucleotides that hinder Notch activity, and their outcome in clinical trials. Although Notch was initially identified as an oncogene, later studies showed that it can also act as a tumor suppressor in certain contexts. Further complexity is added by the existence of numerous Notch family members, which exert different activities and can be differentially targeted by inhibitors, potentially accounting for contradictory data on their therapeutic efficacy. Notably, recent evidence supports the rationale for combinatorial treatments including Notch inhibitors, which appear to be more effective than single agents in fighting cancer.

References

Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S Artavanis-TsakonasB Yedvobnick
Apr 30, 1999·Science·S Artavanis-TsakonasR J Lake
Jan 9, 2001·Journal of Neurochemistry·H F DoveyJ E Audia
Jul 24, 2001·Arthritis and Rheumatism·M NakazawaT Nakajima
Jun 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yue WangKatsutoshi Furukawa
Jan 18, 2005·Experimental Cell Research·Victoriano BaladrónJorge Laborda
Mar 5, 2005·The Journal of Biological Chemistry·Gregory A VidalFrank E Jones
Aug 17, 2005·Genes & Development·Meera V Sundaram
May 19, 2006·Genesis : the Journal of Genetics and Development·Céline SouilholMichel Cohen-Tannoudji
Oct 10, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lin ShanMary E Sunday
Nov 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Teresa PalomeroAdolfo A Ferrando
Dec 16, 2006·Current Molecular Medicine·Lucio MieleBarbara Osborne
Jul 25, 2007·The Journal of Experimental Medicine·Jennifer O'NeilA Thomas Look
Sep 18, 2007·Nature Medicine·Teresa PalomeroAdolfo A Ferrando
Nov 13, 2007·Cancer Cell·Alejandro Gutierrez, A Thomas Look
Jan 29, 2008·Current Topics in Medicinal Chemistry·Richard E Olson, Charles F Albright
Feb 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Xiaofeng ZhengLorenz Poellinger
Apr 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cecilia SahlgrenUrban Lendahl
Sep 3, 2009·The Journal of Biological Chemistry·Guisheng SongLi Wang
Nov 13, 2009·Nature·Raymond E MoelleringJames E Bradner
Nov 17, 2009·Breast Cancer Research and Treatment·Brenda CohenMichael Reedijk
Dec 4, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Benjamin KefasBenjamin Purow
Dec 25, 2009·Molecular Cancer·Suruchi MittalAnnapoorni Rangarajan
Apr 16, 2010·Nature·Yan WuChristian W Siebel
Jul 29, 2010·The Journal of Clinical Investigation·Andrea CasazzaLuca Tamagnone
Dec 17, 2010·Molecular Cancer Therapeutics·Ming LiYulia Nefedova

❮ Previous
Next ❯

Citations

Feb 28, 2019·Journal of Cellular and Molecular Medicine·Hong-Sheng ZhangYing-Hui Huang
Jul 16, 2019·Expert Opinion on Therapeutic Targets·Giorgio AquilaAnna Malaschicheva
Oct 12, 2019·Nature Reviews. Drug Discovery·Soufiane Boumahdi, Frederic J de Sauvage
Jun 23, 2020·SLAS Discovery·Robert J LakeHua-Ying Fan
Nov 6, 2018·Biomedicines·Eike-Benjamin BrauneUrban Lendahl
Jun 14, 2019·Frontiers in Immunology·Francesco Vieceli Dalla SegaPaola Rizzo
May 19, 2019·Journal of Cellular Physiology·Rong WeiJunlong Wu
Dec 10, 2020·Nature Reviews. Drug Discovery·Samarpan MajumderLucio Miele
Jun 23, 2019·Molecular Cancer Therapeutics·Sankaranarayanan KannanPatrick A Zweidler-McKay
Feb 5, 2021·Frontiers in Cell and Developmental Biology·Marika RossiniMauro Tognon
Nov 18, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Letizia PorcelliAmalia Azzariti
Mar 9, 2021·Frontiers in Cell and Developmental Biology·Abdellah AkilBin Ren
Aug 24, 2020·Pathology, Research and Practice·Maryam AkbarzadehMaryam Majidinia

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
xenografts
xenograft
AlphaScreen
antisense oligonucleotides

Software Mentioned

AlphaScreen

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Related Papers

Advances in Experimental Medicine and Biology
Michael Reedijk
Cellular and Molecular Life Sciences : CMLS
U Koch, F Radtke
Asian Pacific Journal of Cancer Prevention : APJCP
Shu-Dong YuQi-Rong Wang
Pharmacology & Therapeutics
Ingrid Espinoza, Lucio Miele
© 2022 Meta ULC. All rights reserved